MiRNA-based therapy for DM: MiRNA-181b increases insulin cell mass and function via down regulation of its target gene, 31/August/2014, 16.21

MiRNA-based therapy for DM: MiRNA-181b increases insulin cell mass and function via down regulation of its target gene, 31/August/2014, 16.21

MiRNA-based therapy for DM: MiRNA-181b increases insulin cell mass and function via down regulation of its target gene, 31/August/2014, 16.21 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, MiRNA-based therapy for DM: MiRNA-181b increases insulin cell mass and function via down regulation of its target gene, 31/August/2014, 16.21, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org.

Significance: This study suggests that pharmacological formulations encompassing “MiRNA-I81b” may be used to treat DM.

Share
Start Typing